Effect of prenatal fetal surveillance on neonatal outcomes in diabetic pregnant patients
Not Applicable
- Conditions
- Diabetes in pregnancy.Diabetes mellitus in pregnancy
- Registration Number
- IRCT20200127046278N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 110
Inclusion Criteria
Diabetic pregnant patients who recieve oral medication or insulin therapy
Gestational age> 28weeks
Consent to participate
Exclusion Criteria
History of chronic diseases, including endocrine diseases (Except diabetes)
History of corticosteroid use
Vascular complications of diabetes
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 5th minute apgar score. Timepoint: after birth. Method of measurement: examination.;Admission to neonatal intensive care unit (NICU). Timepoint: 1 months after birth. Method of measurement: Clinical Records.
- Secondary Outcome Measures
Name Time Method Birth weight. Timepoint: After birth. Method of measurement: Weight scale.;Birth height. Timepoint: After birth. Method of measurement: Meter.;Macrosomia Incidence. Timepoint: After birth. Method of measurement: Physical exam.;Incidence of small for gestational age (SGA). Timepoint: After birth. Method of measurement: Physical exam.;Hypoglycemia incidence. Timepoint: After birth. Method of measurement: Lab test.;Hyperbilirubinemia incidence. Timepoint: After birth. Method of measurement: Lab test.